Management of Suspected Life-Threatening Perioperative Anaphylaxis and Risk Factors for Near-Fatal and Fatal Outcomes: A Retrospective Study in China
Huamei Cai,Xiaowen Liu,Dingyi Wang,Weixia Li,Hongli Ma,Jing Zhao
DOI: https://doi.org/10.2147/TCRM.S406515
2023-05-11
Therapeutics and Clinical Risk Management
Abstract:Huamei Cai, 1, 2, &ast Xiaowen Liu, 1, &ast Dingyi Wang, 3, 4 Weixia Li, 1 Hongli Ma, 1, 2 Jing Zhao 1, 2 1 Department of Anesthesiology, China-Japan Friendship Hospital, Beijing, People's Republic of China; 2 Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China; 3 National Center for Respiratory Medicine & National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine & Chinese Academy of Medical Sciences, Beijing, People's Republic of China; 4 Department of Clinical Research and Data Management Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jing Zhao, Department of Anesthesiology, China- Japan Friendship Hospital, No. 2 Yinghua East Road, Beijing, 100029, People's Republic of China, Tel +86 010 8420 5876, Email Purpose: Perioperative anaphylaxis (POA) is an acute severe systemic hypersensitivity reaction characterized by life-threatening respiratory and circulatory collapse. In our previous study, we reported the epidemiology of suspected POA in China. In the present study, we aimed to elucidate the management and outcomes of these cases and further verify the risk factors for near-fatal and fatal outcomes. Patients and Methods: This was a retrospective study of 447 cases of suspected life-threatening POA encountered at 112 tertiary hospitals in mainland China between September 2018 and August 2019. Patient characteristics, symptoms, duration of hypotension, treatments, and clinical outcomes were documented. Bivariate logistic regression was used to identify risk factors for near-fatal and fatal outcomes. Results: Most cases of suspected POA (89.9%) were recognized and treated within 5 min. Epinephrine was administered as the initial treatment in 232 (51.9%) cases. Corticosteroids (26.6%), other vasoactive drugs (18.3%), and bronchodilators (1.6%) were also administered as the initial treatment instead of epinephrine. The initial dosage of epinephrine (median, 35 μg) was insufficient according to the anaphylaxis guidelines. On multivariable analysis, age ≥ 65 years (odds ratio [OR] 7.48; 95% confidence interval [CI]: 1.33– 41.87, P =0.022), ASA physical status IV (OR 17.68; 95% CI: 4.53-68.94; P < 0.001), and hypotension duration ≥ 15 min (OR 3.63; 95% CI: 1.11– 11.87; P =0.033) were risk factors for fatal and near-fatal outcomes. Conclusion: Most cases in this study were managed in a timely manner, but the epinephrine application should be optimized according to the guidelines. Age ≥ 65 years, ASA physical status IV, and long-term hypotension were risk factors for near-fatal and fatal outcomes. Keywords: perioperative anaphylaxis, epinephrine, risk factors, perioperative outcomes Life-threatening perioperative anaphylaxis (POA) is a severe, systemic hypersensitivity reaction that may lead to death during anesthesia. 1 Clinical signs of life-threatening POA primarily affect the cardiovascular system (severe hypotension, tachycardia, or cardiac arrest) and respiratory system (bronchospasm, or increased airway pressure in ventilated patients); these symptoms may or may not be accompanied by skin changes. 1 The reported incidence of POA varies between countries and ranges from one in 10,000 to one in 20,000. 2 According to an epidemiological study, the incidence rate of life-threatening POA in China was 1 in 11,360 which varied significantly by region. 3 The mortality rate of severe POA was 2%. 3 Many anesthesiologists lack experience in diagnosing and managing life-threatening POA because of the low incidence of severe POA. The National Audit Project (NAP6) study in the UK investigated the management and outcomes of life-threatening POA, leading to an increased focus on this subject. 4 Several studies have identified the need to improve the diagnosis of POA, epinephrine administration, and fluid resuscitation. 4–8 The management of severe POA is a challenge for anesthesiologists owing to its low incidence and high mortality rate. Epinephrine is the first-line treatment for anaphylaxis. 9,10 Epinephrine, as an alpha-receptor and beta-receptor agonist, reverses peripheral vasodilation, reduces tissue edema, and dilates the bronchial airways instantly by inhibiting the activation of mast cells and suppressing histamine and leukotriene release. 11,12 The guidelines recommen -Abstract Truncated-
health care sciences & services